Hepatic hydrothorax;Der hepatische hydrothorax

Zeitschrift fur Gastroenterologie

Volumn 43, Issue 12, 2005, Pages 1319-1328

  Bozkurt, S ^a   Stein, Jürgen ^a   Teuber, G ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Ascites; Hepatic hydrothorax; Liver transplantation; Spontaneous bacterial empyema; TIPS

Indexed keywords

ANTIBIOTIC AGENT; DIURETIC AGENT;

ANTIBIOTIC THERAPY; ASCITES; EFFUSION; EMPYEMA; HUMAN; HYDROTHORAX; LIVER CIRRHOSIS; LIVER HYDROTHORAX; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY; PERITONEAL CAVITY; PLEURA CAVITY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; SODIUM RESTRICTION; SPONTANEOUS BACTERIAL EMPYEMA; THORACOCENTESIS; TREATMENT INDICATION; WATER DEPRIVATION;

EMPYEMA, PLEURAL; HYDROTHORAX; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PHYSICIAN'S PRACTICE PATTERNS; PORTACAVAL SHUNT, SURGICAL; PRACTICE GUIDELINES; PROGNOSIS; TREATMENT OUTCOME;

EID: 29944446589     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858742     Document Type: Review

References (81)

1. Johnston RF, Loo RV. Hepatic hydrothorax: studies to determine the source of the fluid and report of thirteen cases. Ann Intern Med 1964; 61: 385-401
2. Morrow CS, Kantor M, Armen RN. Hepatic hydrothorax. Ann Intern Med 1958; 49: 193-203
3. Alberts WM, Salem AJ, Solomon DA et al. Hepatic hydrothorax. Cause and management. Arch Intern Med 1991; 51: 2383-2388
4. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis 1997; 17: 227-232
5. Xiol X, Guardiola J. Hepatic hydrothorax. Curr Opin PuIm Med 1998; 4: 239-421
6. Emerson PA, Davies JH. Hydrothorax complicating ascites. Lancet 1955; 268: 487-488
7. Lieberman FL, Hidemura R, Peters RL et al. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med 1966; 64: 341-351
8. Xiol X, Castellvi JM, Guardiola J et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996; 23: 719-723
9. Streifler J, Pitlik S, Dux S et al. Spontaneous bacterial pleuritis in a patient with cirrhosis. Respiration 1984; 46: 382-385
10. Cardenas A, Kelleher T, Chopra S. Hepatic hydrothorax. Aliment Pharmacol Ther 2004; 20: 271-279
11. Alagiakrishnan K, Patel PJ. Left-sided hepatic hydrothorax with ascites. Int J Clin Pract 1999; 53: 225-226
12. Lazaridis KN, Frank JW, Krowka MJ et al. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999; 107: 262-267
13. Xiol X, Castellote J, Baliellas C et al. Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases. Hepatology 1989; 11: 365-370
14. Kaplan LM, Epstein SK, Schwartz SL et al. Clinical, echocardiographic, and hemodynamic evidence of cardiac tamponade caused by large pleural effusions. Am J Respir Crit Care Med 1995; 151: 904-908
15. Rössle M, Siegerstetter V. Der hepatische Hydrothorax. Dtsch Med Wschr 1998; 123: 1485-1489
16. Castellote J, Gornals J, Lopez C et al. Acute tension hydrothorax: a life-threatening complication of cirrhosis. J Clin Gastroenterol 2002; 34: 588-589
17. Lieberman FL, Peters RL. Cirrhotic hydrothorax: Further evidence that an acquired diaphragmatic defect is at fault. Arch Intern Med 1970; 25: 114-117
18. Chen A, Ho YS, Tu YC et al. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol 1988; 10: 663-666
19. Thomas L. Labor und Diagnose. Frankfurt/Main: TH Books, 6. Auflage 2005: 1827-1829
20. Ackerman Z, Reynolds TB. Evaluation of pleural fluid in patients with cirrhosis. J Clin Gastroenterol 1997; 25: 619-622
21. Xiol X, Cortes R, Castellote J et al. Utility and complications of thoracocentesis in cirrhotic patients. Hepatology 1997; 26: 286A, Abstract
22. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27: 669-674
23. Rimola A, Garcia-Tsao G, Navasa M et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142-153
24. Fernandez J, Navasa M, Gomez J et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-148
25. Zenda T, Miyamoto S, Murata S et al. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging. Am J Gastroenterol 1998; 93: 2288-2289
26. Davila F. Massive hepatic hydrothorax without ascites: the complexities and "costs" of management. Amer J Gastroenterol 1988; 83: 333-334
27. Giacobbe A, Facciorusso D, Tonti P et al. Hydrothorax complicating cirrhosis in the absence of ascites. J Clin Gastroenterol 1993; 17: 271-272
28. Mentes BB, Kayan B, Gorgul A et al. Hepatic hydrothorax in the absence of ascites: report of two cases and review of the mechanism. Dig Dis Sci 1997; 42: 781-788
29. Kakizaki S, Katakai K, Yoshinaga T et al. Hepatic hydrothorax in the absence of ascites. Liver 1998; 18: 216-220
30. Serena A, Aliaga L, Richter JA et al. Scintigraphic demonstration of a diaphragmatic defect as the cause of massive hydrothorax in cirrhosis. Eur J Nucl Med 1985; 11: 46-48
31. Benet A, Vidal F, Toda R et al. Diagnosis of hepatic hydrothorax in the abscence of ascites by intraperitoneal injection of 99 m-Tc-Fluor colloid. Postgrad Med J 1992; 68: 153
32. LeVeen HH, Piccone VA, Hutto RB. Management of ascites with hydrothorax. Amer J Surg 1984; 148: 210-213
33. Rubinstein D, McInnes IE, Dudley FJ. Hepatic hydrothorax in the absence of clinical ascites: Diagnosis and management. Gastroenterology 1985; 88: 188-191
34. Fleig WE, Stange EF, Hunecke R et al. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propanolol and sclerotherapy. Hepatology 1987; 7: 355-361
35. Higashi H, Kitano S, Hashizume M et al. A prospective randomized trial of schedules for sclerosing esophagal varices. Hepato-Gastroenterol 1989; 36: 337-340
36. Kahn D, Jones B, Bornman PC et al. Incidence and management of complications after injection sclerotherapy: a ten year prospective evaluation. Surgery 1989; 105: 160-165
37. Roberts LR, Kamath PS. Ascites and hepatorenal syndrome: pathophysiology and management. Mayo Clin Proc 1996; 71: 874-881
38. Moore KP, Wong F, Gines P et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-266
39. Runyon B. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-856
40. Perez-Ayuso RM, Arroyo V, Planas R et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 1983; 84: 961-968
41. Laffi G, Marra F, Buzzelli G et al. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. Hepatology 1991; 13: 1101-1105
42. Gerbes AL, Bertheau-Reitha U, Falkner C et al. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial. J Hepatol 1993: 353-358
43. Sort P, Navasa M, Arroyo V et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-409
44. Arroyo V, Ginès P, Gerbes AL et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164-176
45. Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81: 566-567
46. Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest 1987; 91: 817-822
47. Borchardt J, Smirnov A, Metchnik L et al. Treating hepatic hydrothorax. BMJ 2003; 326: 751-752
48. Sherman SC. Re-Expansion pulmonary edema: a case report and review of the current literature. J Emerg Med 2003; 24: 23-27
49. Rössle M, Haag K, Ochs A et al. The transjugular-intrahepatic- portosystemic stent-shunt procedure for variceal bleeding. New Engl J Med 1994; 330: 165-171
50. Kamath PS, McKusick MA. Transvenous intrahepatic portosystemic shunts. Gastroenterology 1996; 111: 1700-1705
51. Boyer T. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003; 124: 1700-1710
52. Strauss RM, Martin LG, Kaufman SL et al. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994; 89: 1520-1522
53. Gordon FD, Anastopoulos HT, Crenshaw W et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997; 25: 1366-1369
54. Siegerstetter V, Deibert P, Ochs A et al. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: longterm results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13: 529-534
55. Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002; 13: 385-390
56. Shiffman ML, Jeffers L, Hoofnagel JH et al. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications. A conference sponsored by the national digestive disease advisory board. Hepatology 1995; 22: 1591-1597
57. Rössle M. The transjugular intrahepatic portosystemic shunt. J Hepatol 1996; 25: 224-231
58. Chalasani N, Clark WS, Martin LG et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118: 138-144
59. Malinchoc M, Kamath PS, Gordon FD et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
60. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470
61. Boiteau R, Tenaillon A, Law-Koune JD et al. Treatment for cirrhotic hydrothorax with cpap on mask and tetracycline pleural sclerosis. Amer Rev Resp Dis 1990; 141: A770
62. Falchuk KR, Jacoby I, Colucci WS et al. Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis. Gastroenterology 1977; 72: 319-321
63. Ikard RW, Sawyers JL. Persistent hepatic hydrothorax after peritoneojugular shunt. Arch Surg 1980; 115: 1125-1127
64. Giacobbe A, Facciorusso D, Barbano F et al. Hepatic hydrothorax. Diagnosis and management. Clin nucl Med 1996; 21: 56-60
65. de Milanez Campos JR, Filho LO, de Campos Werebe E et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest 2000; 118: 13-17
66. Mouroux J, Perrin C, Venissac N et al. Management of pleural effusion of cirrhotic origin. Chest 1996; 109: 1093-1096
67. Takayama T, Kurokawa Y, Kaiwa Y et al. A new technique of thoracoscopic pleurodesis for refractory hepatic hydrothorax. Surg Endosc 2004; 18: 140-143
68. Ferrante D, Arguedas MR, Cerfolio RJ et al. Video-assisted thoracoscopy surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol 2002; 97: 3172-3175
69. Hobbs CL, Mullen JL, Rosato EF. Peritoneovenous shunt for hydrothorax associated with ascites. Arch Surg 1982; 117: 1233-1234
70. Montanari M, Orsi P, Pugliano G. Hepatic hydrothorax without diaphragmatic defect. An original surgical treatment. J Cardiovasc Surg 1996; 37: 425-427
71. Park SZ, Shrager JB, Allen MS et al. Treatment of refractory, nonmalignant hydrothorax with a pleurovenous shunt. Ann thorac Surg 1997; 63: 1777-1779
72. Gines P, Arroyo V, Vargas V et al. Parcentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325: 829-835
73. D'Amico G, Morabito A, Pagliaro L et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-475
74. Gines P, Fernández-Esparrach G. Prognosis of cirrhosis with ascites. In: Arroyo V, Gines P, Rodes J, Schrier RW (Hrsg). Ascites and renal dysfunction in liver disease: pathogenesis, diagnosis, and treatment. Malden/Mass: Blackwell Science, 1999: 431-441
75. Conn HO, Fessel JM. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine 1971; 50: 161-197
76. Coral G, de Mattos AA, Damo DF et al. Prevalence and prognosis of spontaneous bacterial peritonitis. Experience in patients from a general hospital in Porto Alegre, RS, Brazil (1991-2000). Arq Gastroenterol 2002; 39: 158-162
77. Haskal ZJ, Zuckerman J. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest 1994; 106: 1293-1295
78. Andrade RJ, Martin-Palanca A, Fraile JM et al. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the abscence of ascites. J Clin Gastroenterol 1996; 22: 305-307
79. Nolte W, Figulla HR, Ringe B et al. Refraktärer Hydrothorax bei primär biliärer Zirrhose. Dtsch Med Wschr 1997; 122: 1275-1280
80. Jeffries MA, Kazanjian S, Wilson M et al. Transjugular intrahepatic portosystemic shunt and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl Surg 1998; 4: 416-423
81. Truninger K, Frey LD. Hepatischer Hydrothorax ohne Aszites. Schweiz Med Wochenschr 2000; 130: 1706